
Ambalal Sarabhai vs Asarfi Hospital vs QMS Medical: Which Stock Should You Track
Ambalal Sarabhai Enterprises PE 23.29, mkt cap Rs 316 crore. Asarfi Hospital PE 22.08, mkt cap Rs 393 crore. QMS Medical Allied Services PE 29.57, mkt cap Rs 372 crore.
Updated: 16 Oct 2026 • 9:48 am
Posted by:

Quick Answer
Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services is a side-by-side comparison of three companies from the pharma and healthcare space. On this comparison, Ambalal Sarabhai Enterprises carries a market capitalisation of about Rs 316 crore, against Rs 393 crore for Asarfi Hospital and Rs 372 crore for QMS Medical Allied Services, with return on equity of 11.24%, 17.47% and 9.67% respectively. Each company's numbers are presented here without a declared preference, since the right stock depends on an investor's own criteria.
Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services starts with the core numbers most investors compare within the pharma and healthcare segment: market capitalisation, valuation multiples, profitability, dividend yield and the latest quarterly results. Figures below are sourced as of October 2026 and will shift with daily price moves.
All three names sit in the pharma and healthcare bucket, which makes them a natural set to place side by side rather than a random trio of unrelated businesses. The sections below cover the company profiles, a valuation table, the latest quarter and a five-quarter trend for revenue and net profit.
Click Here – Get Free Investment Predictions
Ambalal Sarabhai Enterprises, Asarfi Hospital and QMS Medical Allied Services: Company Overview
Ambalal Sarabhai Enterprises is a listed Indian company in the pharma and healthcare space, tracked here on book value, return ratios and valuation alongside its peers in this comparison. It has a market capitalisation of about Rs 316 crore, a return on equity of 11.24% and a book value of Rs 20.66 per share. Its quarterly revenue moved from Rs 48.70 crore in June 2025 to Rs 45.59 crore in June 2026, a change of -6.4%.
Asarfi Hospital is a listed Indian company in the pharma and healthcare space, tracked here on book value, return ratios and valuation alongside its peers in this comparison. It has a market capitalisation of about Rs 393 crore, a return on equity of 17.47% and a book value of Rs 51.79 per share. Its quarterly revenue moved from Rs 37.10 crore in June 2025 to Rs 48.10 crore in June 2026, a change of +29.6%.
QMS Medical Allied Services is a listed Indian company in the pharma and healthcare space, tracked here on book value, return ratios and valuation alongside its peers in this comparison. It has a market capitalisation of about Rs 372 crore, a return on equity of 9.67% and a book value of Rs 53.88 per share. Its quarterly revenue moved from Rs 46.82 crore in June 2025 to Rs 57.29 crore in June 2026, a change of +22.4%.
Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services: Valuation and Profitability Snapshot
| Metric | Ambalal Sarabhai Enterprises | Asarfi Hospital | QMS Medical Allied Services |
|---|---|---|---|
| Market Cap (approx.) | Rs 316 crore | Rs 393 crore | Rs 372 crore |
| PE Ratio (TTM) | 23.29 | 22.08 | 29.57 |
| PB Ratio | 2.00 | 3.86 | 3.57 |
| Return on Equity (ROE) | 11.24% | 17.47% | 9.67% |
| EPS (TTM, Rs) | 1.77 | 9.05 | 6.51 |
| Dividend Yield | 0.00% | 0.00% | 2.60% |
| Debt to Equity | 0.36 | 0.54 | 0.65 |
| Book Value per Share (Rs) | 20.66 | 51.79 | 53.88 |
Check the Univest Screener for Live Data
On valuation, Ambalal Sarabhai Enterprises trades at a PE of 23.29 and a PB of 2.00, Asarfi Hospital at a PE of 22.08 and a PB of 3.86, while QMS Medical Allied Services trades at a PE of 29.57 and a PB of 3.57. On return on equity, the three post 11.24%, 17.47% and 9.67% respectively, and on dividend yield they stand at 0.00%, 0.00% and 2.60%. Asarfi Hospital has the highest market capitalisation of the three at Rs 393 crore, while Ambalal Sarabhai Enterprises has the lowest at Rs 316 crore. QMS Medical Allied Services has the highest PE ratio of the three at 29.57, while Asarfi Hospital has the lowest at 22.08. Asarfi Hospital has the highest return on equity of the three at 17.47%, while QMS Medical Allied Services has the lowest at 9.67%. QMS Medical Allied Services has the highest debt to equity ratio of the three at 0.65, while Ambalal Sarabhai Enterprises has the lowest at 0.36. Debt to equity is 0.36, 0.54 and 0.65 for the three respectively.
Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services: Latest Quarterly Results
| Company | Latest Quarter Revenue | Latest Quarter Net Profit | YoY Change (Revenue) | QoQ Change (Revenue) | YoY Change (Net Profit) |
|---|---|---|---|---|---|
| Ambalal Sarabhai Enterprises | Rs 45.59 crore | Rs 3.98 crore | -6.4% | -33.1% | -51.6% |
| Asarfi Hospital | Rs 48.10 crore | Rs 4.27 crore | +29.6% | +4.8% | +36.9% |
| QMS Medical Allied Services | Rs 57.29 crore | Rs 3.96 crore | +22.4% | +28.3% | +25.3% |
Quarterly figures above are the most recent reported quarter for each company (Q1 FY27, quarter ended June 2026), compared with the year-ago and preceding quarter. A percentage change in net profit is shown as NA where the comparison quarter was a loss or the latest quarter is a loss, since the percentage is not meaningful in that case.
Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services: Five-Quarter Revenue and Net Profit Trend
The five-quarter view below shows how revenue and net profit moved from June 2025 to June 2026 for each company in Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services, which helps separate a one-quarter move from a steadier pattern.
Quarterly revenue (Rs crore)
| Quarter | Ambalal Sarabhai Enterprises | Asarfi Hospital | QMS Medical Allied Services |
|---|---|---|---|
| June 2025 | Rs 48.70 crore | Rs 37.10 crore | Rs 46.82 crore |
| September 2025 | Rs 46.07 crore | Rs 45.65 crore | Rs 44.92 crore |
| December 2025 | Rs 54.58 crore | Rs 47.58 crore | Rs 37.56 crore |
| March 2026 | Rs 68.10 crore | Rs 45.88 crore | Rs 44.64 crore |
| June 2026 | Rs 45.59 crore | Rs 48.10 crore | Rs 57.29 crore |
Quarterly net profit (Rs crore)
| Quarter | Ambalal Sarabhai Enterprises | Asarfi Hospital | QMS Medical Allied Services |
|---|---|---|---|
| June 2025 | Rs 8.22 crore | Rs 3.12 crore | Rs 3.16 crore |
| September 2025 | -Rs 0.56 crore | Rs 4.20 crore | Rs 3.58 crore |
| December 2025 | Rs 3.64 crore | Rs 5.42 crore | Rs 3.17 crore |
| March 2026 | Rs 6.50 crore | Rs 3.92 crore | Rs 1.88 crore |
| June 2026 | Rs 3.98 crore | Rs 4.27 crore | Rs 3.96 crore |
Ambalal Sarabhai Enterprises reported revenue of Rs 48.70 crore in June 2025 and Rs 45.59 crore in June 2026, a change of -6.4% across the period. Its highest quarterly revenue in this window was Rs 68.10 crore in March 2026. Net profit stood at Rs 3.98 crore in June 2026, which is a net profit margin of 8.73%. Ambalal Sarabhai Enterprises reported a net loss in September 2025.
Asarfi Hospital reported revenue of Rs 37.10 crore in June 2025 and Rs 48.10 crore in June 2026, a change of +29.6% across the period. Its highest quarterly revenue in this window was Rs 48.10 crore in June 2026. Net profit stood at Rs 4.27 crore in June 2026, which is a net profit margin of 8.88%.
QMS Medical Allied Services reported revenue of Rs 46.82 crore in June 2025 and Rs 57.29 crore in June 2026, a change of +22.4% across the period. Its highest quarterly revenue in this window was Rs 57.29 crore in June 2026. Net profit stood at Rs 3.96 crore in June 2026, which is a net profit margin of 6.91%.
Download the Univest iOS App or Univest Android App to track Ambalal Sarabhai Enterprises, Asarfi Hospital and QMS Medical Allied Services live prices.
What Should Investors Look at Beyond These Numbers?
Beyond the metrics above, investors comparing these three pharma and healthcare names should track quarter-on-quarter revenue and margin trends, management commentary on demand and cost drivers, and factors specific to the segment such as regulatory approvals, order flow, raw material costs and the small revenue base that makes quarterly results swing. A single-quarter snapshot can shift quickly, and smaller companies in particular can show wide swings from one quarter to the next.
It also helps to read the latest quarterly filings and investor presentations of Ambalal Sarabhai Enterprises, Asarfi Hospital and QMS Medical Allied Services directly, since the figures here come from standardised data and do not capture company-specific context such as one-time items, order timing or promoter actions.
Conclusion
Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services highlights how differently three companies in the same pharma and healthcare segment can look across valuation, profitability and dividend metrics, even when operating in a similar space. This comparison does not declare a winner; investors should weigh these figures against their own research and risk appetite. Please read the disclaimer below before making any investment decision.
Disclaimer: Data and figures in this article are sourced from publicly available information as of October 2026 and may not reflect real-time prices. Please verify all data independently before making any investment decision. This comparison does not recommend or endorse any single stock over another; investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services
What is the market cap difference between Ambalal Sarabhai Enterprises, Asarfi Hospital and QMS Medical Allied Services?
Ans. As of October 2026, Ambalal Sarabhai Enterprises has a market cap of approximately Rs 316 crore, Asarfi Hospital is at approximately Rs 393 crore, and QMS Medical Allied Services is at approximately Rs 372 crore. Asarfi Hospital is the largest of the three, and its market capitalisation is about 1.2 times that of Ambalal Sarabhai Enterprises, the smallest. Market capitalisation reflects the size of a company in the market rather than the quality of its business, so a larger value does not by itself signal a higher quality company. These figures move with the share price every trading day, which is why the table above should be read as a snapshot rather than a fixed ranking in the Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services comparison.
What are the PE and PB ratios of Ambalal Sarabhai Enterprises, Asarfi Hospital and QMS Medical Allied Services?
Ans. As of October 2026, the PE ratios stand at 23.29, 22.08 and 29.57 respectively, and the price to book ratios stand at 2.00, 3.86 and 3.57 respectively. All three companies have a positive trailing PE, so the multiples can be compared directly. The PE ratio shows how much investors pay for each rupee of trailing earnings, while the PB ratio compares the market value with the net assets on the balance sheet. Both multiples should be read against the segment norms for pharma and healthcare and against each company's own growth and earnings stability, because a high multiple can reflect expected growth or simply a small earnings base.
Which of the three has the highest ROE?
Ans. Ambalal Sarabhai Enterprises, Asarfi Hospital and QMS Medical Allied Services post ROE of 11.24%, 17.47% and 9.67% respectively as of October 2026. Asarfi Hospital has the highest return on equity of the three at 17.47%, while QMS Medical Allied Services has the lowest at 9.67%. Return on equity measures how much profit a company generates on the capital contributed by its shareholders, so it is a useful gauge of how efficiently equity is being used. A negative ROE points to losses over the period, and a very high ROE can sometimes result from a small equity base rather than operating performance. It is therefore worth reading ROE together with debt levels and the five-quarter profit trend before drawing any conclusion from the Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services figures.
Which of these three stocks pays the highest dividend yield?
Ans. Ambalal Sarabhai Enterprises, Asarfi Hospital and QMS Medical Allied Services carry dividend yields of 0.00%, 0.00% and 2.60% respectively as of October 2026. Dividend yield is the annual dividend per share expressed as a percentage of the current share price, so it changes whenever the price changes. A low or zero yield is common among companies that retain profits to fund expansion, repay debt or absorb losses, and it does not by itself say anything about business quality. Investors who care about income should also check how consistently each company has paid dividends and what share of profit it distributes.
What is the debt to equity ratio for Ambalal Sarabhai Enterprises, Asarfi Hospital and QMS Medical Allied Services?
Ans. Ambalal Sarabhai Enterprises carries a debt to equity of 0.36, Asarfi Hospital of 0.54, and QMS Medical Allied Services of 0.65. QMS Medical Allied Services has the highest debt to equity ratio of the three at 0.65, while Ambalal Sarabhai Enterprises has the lowest at 0.36. The debt to equity ratio compares total borrowings with shareholders' funds, and a higher figure means the company relies more on borrowed money to run its business. What counts as a comfortable level differs by segment, since some businesses in pharma and healthcare need heavy capital and carry more debt than others. Investors usually read this ratio alongside interest costs and cash generation to judge how well each company can service its borrowings in the Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services comparison.
What were the latest quarterly revenue and net profit of Ambalal Sarabhai Enterprises, Asarfi Hospital and QMS Medical Allied Services?
Ans. For Q1 FY27 (quarter ended June 2026), Ambalal Sarabhai Enterprises reported revenue of Rs 45.59 crore and net profit of Rs 3.98 crore, Asarfi Hospital reported revenue of Rs 48.10 crore and net profit of Rs 4.27 crore, and QMS Medical Allied Services reported revenue of Rs 57.29 crore and net profit of Rs 3.96 crore. Compared with the quarter ended June 2025, revenue changed by -6.4% for Ambalal Sarabhai Enterprises, +29.6% for Asarfi Hospital and +22.4% for QMS Medical Allied Services. A single quarter can be affected by seasonality, one-time items and the timing of orders, so the five-quarter tables above give a clearer sense of direction than any one result. A net loss in a quarter does not always mean a troubled business, but it does call for a closer look at costs, debt and the reasons behind the swing in the Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services results.
Does this comparison recommend one of Ambalal Sarabhai Enterprises, Asarfi Hospital and QMS Medical Allied Services?
Ans. This comparison does not declare one stock ahead of another; each company scores differently across valuation, profitability and dividend metrics, and the right fit depends on an individual investor's own criteria and research. Instead of a verdict, the tables above lay out the figures so that readers can weigh them against their own goals, time horizon and tolerance for risk. For companies in pharma and healthcare, it also helps to look at factors such as regulatory approvals, order flow, raw material costs and the small revenue base that makes quarterly results swing. Reading the latest filings and investor presentations of Ambalal Sarabhai Enterprises, Asarfi Hospital and QMS Medical Allied Services directly, and speaking to a SEBI registered adviser where needed, is a sensible step before acting on any numbers shown in Ambalal Sarabhai Enterprises vs Asarfi Hospital vs QMS Medical Allied Services.
Recent Articles

Is Bondada Engineering the Best Stock in Its Sector? A Look at the Numbers
15 October 2026

Is JSW Dulux the Best Stock in Its Sector? A Look at the Numbers
15 October 2026

Is RailTel Corporation of India the Best Stock in Its Sector? A Look at the Numbers
15 October 2026

Is BlackBuck the Best Stock in Its Sector? A Look at the Numbers
15 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Is Bondada Engineering the Best Stock in Its Sector? A Look at the Numbers
Is JSW Dulux the Best Stock in Its Sector? A Look at the Numbers
Is RailTel Corporation of India the Best Stock in Its Sector? A Look at the Numbers
Is BlackBuck the Best Stock in Its Sector? A Look at the Numbers
Is Zen Technologies the Best Stock in Its Sector? A Look at the Numbers

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





